Gua Sha
Gua Sha (Scraping Therapy)
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Evidence is preliminary and mixed. The strongest mechanistic data come from the Nielsen 2007 microcirculation pilot (11 healthy subjects), which is physiological, not a clinical outcome trial. For neck pain, a single-session randomized trial (Braun et al., 2011, Pain Medicine, 48 patients) reported greater short-term improvement in pain at motion, neck disability, and quality of life versus a heat pad at 7 days. A 2010 systematic review of musculoskeletal pain (5 RCTs and 2 controlled trials, 716 participants, all China-based) rated every included study at high risk of bias and concluded that re-analysis "failed to show the claimed effectiveness" and that current evidence is insufficient. A 2018 systematic review and meta-analysis for perimenopausal symptoms (6 RCTs) reported that Gua Sha added to conventional care improved Kupperman Index and quality-of-life scores but graded most trials as low methodological quality. Larger, blinded, sham-controlled trials are absent.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Surface microcirculation increase | 3 of 5 | Reproducibly reported with laser Doppler imaging (Nielsen 2007); a mechanistic finding in healthy subjects, not a clinical outcome. |
| Chronic neck pain (short-term) | 2 of 5 | One small single-session RCT (Braun 2011, n=48) reports benefit vs heat pad at 7 days; not yet replicated in larger blinded trials. |
| Perimenopausal symptoms | 2 of 5 | 2018 meta-analysis of 6 RCTs favors Gua Sha plus usual care, but most trials are low quality with high heterogeneity. |
| General musculoskeletal pain | 1 of 5 | 2010 systematic review (716 participants) found high risk of bias throughout and judged evidence insufficient to show effectiveness. |
| Infection, respiratory, or systemic disease | 0 of 5 | Traditional and proponent claims lack controlled clinical support; no credible trial evidence. |
What can go wrong
Petechiae and bruise-like marks are the intended therapeutic endpoint and resolve over days; transient soreness, redness, and dermatitis are common. Reported complications include skin infection from unsterilized tools and, rarely, more serious injury. People on anticoagulants or with bleeding disorders, fragile skin, or over broken or infected skin should avoid the technique or seek professional guidance. A practical clinical hazard is misidentification: the marks have been mistaken for inflicted trauma in healthcare and forensic settings.
Gua Sha is a manual scraping therapy from China in which a smooth-edged tool (traditionally water buffalo horn, jade, ceramic spoon, or a coin) is pressed and stroked across oiled skin until small reddish petechiae, the "sha," appear. Centuries old and formalized within traditional Chinese medicine by the Ming Dynasty, it persists as both a folk household remedy and a clinic technique, and travels under regional names such as Vietnam's cao gio and Indonesia's kerokan. Practitioners describe it as moving blood and qi and releasing pathogenic "wind" to relieve muscle pain, stiffness, and a range of complaints; a smaller cosmetic facial version is now widely marketed for skin tone and contour. The measurable, repeatable effect reported in instrumented studies is a sharp short-term increase in surface microcirculation. The clinical evidence is thinner: a few small randomized trials and systematic reviews suggest possible short-term benefit for neck pain and perimenopausal symptoms, but reviewers consistently flag low study quality and high risk of bias, and broader disease claims are unsupported. Enel positions Gua Sha as a low-cost somatic practice with a plausible local mechanism and honestly limited outcome data.
A centuries-old Chinese scraping technique that deliberately raises bruise-like marks; proponents say it moves blood and eases pain and stiffness.
How it is supposed to work
Established mechanism: instrumented studies report that pressured scraping raises localized surface microcirculation. A laser Doppler imaging pilot in healthy subjects (Nielsen et al., 2007) measured roughly a fourfold rise in surface-tissue perfusion that the authors say persisted for about 25 minutes, accompanied by the petechiae that define a "sha" response. Proposed and contested mechanism: practitioners describe Gua Sha as moving stagnant qi and blood and "releasing" pathogenic wind, and some researchers have hypothesized that the transient perfusion increase, possible anti-inflammatory and heme-oxygenase signaling from the controlled micro-injury, and counter-irritation could explain reported relief of local and distal muscle pain. These downstream pain pathways are inferred, not established. The traditional qi or wind framing is a theoretical model, not a verified physiological account.
What people get wrong
Often saidThe bruise-like marks mean toxins or "bad blood" are being drawn out of the body.
ActuallyThe marks are petechiae from small capillaries breaking under pressure. They reflect localized microcirculation and micro-injury, not toxin removal.
Often saidGua Sha is a proven treatment for infections, fevers, and respiratory disease.
ActuallyThose traditional and proponent claims have no controlled clinical support. Documented research is limited mainly to musculoskeletal pain and perimenopausal symptoms, and even there the evidence is weak.
Who profits, and who pushes back
Arya Nielsen, PhD
Gua Sha produces a measurable, repeatable increase in surface microcirculation, and patients report relief in both treated and untreated areas; it deserves serious study rather than dismissal.
Authors, 2010 musculoskeletal pain systematic review
Although several studies reported favorable effects, our re-analysis failed to confirm the claimed effectiveness, and current evidence is insufficient to show that Gua Sha is effective in pain management.
Marcus Braun, MD, et al.
A single Gua Sha treatment produced a significant short-term improvement in pain at motion and neck disability compared with a heat pad, though larger and longer trials are needed.
Cosmetic Gua Sha tool retailer
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Daily facial gua sha lifts, sculpts, and de-puffs by boosting circulation and lymphatic flow for a more contoured, radiant complexion.
Where the research comes from
Most of the published research on this comes from one place. 100% of it is from China. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| China | 100% |
| Vietnam | 80% |
| Indonesia | 75% |
| United States (diaspora and cosmetic market) | 60% |
| Europe | 40% |
How we got here
Gua Sha originates in China, where scraping the skin with smooth stones, bone, and coins to relieve pain and "release wind" is documented across centuries of folk practice and was formalized within traditional Chinese medicine by the Ming Dynasty (1368 to 1644), when texts described it as a treatment for "sha" syndromes attributed to wind, cold, or stagnation. The name pairs "gua" (to scrape) with "sha" (sand), the term for the reddish petechiae raised during treatment. During the Qing Dynasty (1644 to 1912) the technique was widely applied in epidemic illness, including smallpox. From China the practice spread across Southeast Asia, becoming "cao gio" (literally "to scrape wind") in Vietnam and "kerokan" or "kerik" in Indonesia and Java, where it remains a common household remedy. It travels today with Chinese, Vietnamese, Cambodian, and Indonesian diaspora communities worldwide.
The practice grew out of Chinese folk scraping traditions using stones, bone, and coins, with antecedents traced by some accounts to neolithic bian-stone therapy and broadly to ancient scraping techniques. It was formalized in TCM literature by the Ming Dynasty (1368 to 1644) as a treatment for "sha" disorders, and during the Qing Dynasty it was deployed in epidemic conditions including smallpox. Over centuries it diffused across Southeast Asia, becoming cao gio in Vietnam and kerokan or kerik in Indonesia and Java, each adapting local tools and oils. In the late twentieth and early twenty-first centuries Gua Sha entered Western integrative-medicine clinics and, separately, a global cosmetic market for facial gua sha stones. Modern instrumented research began with the 2007 microcirculation pilot, which gave the traditional sha response a measurable physiological correlate.
- Ming Dynasty (1368-1644)Scraping therapy formalized in Chinese medical texts as treatment for "sha" syndromes.
- Qing Dynasty (1644-1912)Widely applied in epidemic illness in China, including smallpox; spreads across Southeast Asia as cao gio and kerokan.
- 2007Nielsen et al. publish laser Doppler pilot reporting a fourfold, roughly 25-minute rise in surface microcirculation.
- 2010Systematic review of musculoskeletal pain (716 participants) finds high risk of bias and insufficient evidence of effectiveness.
- 2011-2018Braun neck-pain RCT (2011) and perimenopausal meta-analysis (2018) report benefits while flagging small size and low quality; cosmetic facial Gua Sha goes global.
How it is understood
Gua Sha and its regional cousins (cao gio, kerokan) remain living household and clinical traditions across China and Southeast Asia and within diaspora families. The characteristic marks have repeatedly been mistaken for signs of physical abuse by clinicians unfamiliar with the practice, a documented source of cross-cultural conflict in emergency and pediatric care.
Where scholars disagree
Gua Sha is a living tradition belonging to Chinese and Southeast Asian (Vietnamese cao gio, Indonesian kerokan) communities and their diaspora. Its recent repackaging as a global "facial gua sha" cosmetic product line, sold largely detached from its medical and cultural context by Western direct-to-consumer brands, raises active appropriation and sovereignty concerns among practitioners and community members about extraction, renaming, and commercialization of the practice.
The clinical finding (a measurable short-term rise in surface microcirculation and patient-reported pain relief) is treated separately from the mechanistic explanation, which is contested. Researchers favor a physiological account (transient perfusion increase, micro-injury signaling, counter-irritation), while the traditional framework explains effects as movement of qi and blood and release of pathogenic wind. No account is fully verified for the reported distal pain relief.
Integrative-medicine researchers (e.g., Nielsen et al.)
Effects are explained by measurable physiology: pressured scraping produces a transient local increase in microcirculation plus possible anti-inflammatory and counter-irritation effects from controlled micro-injury.
What it rests onLaser Doppler imaging documenting a roughly fourfold, ~25-minute surface perfusion rise (Nielsen 2007); downstream pain pathways remain inferred, not established.
Traditional Chinese medicine practitioners
Gua Sha works by moving stagnant qi and blood and releasing pathogenic "wind," resolving "sha" syndromes.
What it rests onCenturies of documented TCM textual and clinical practice since the Ming Dynasty; this qi/wind framing is a traditional theoretical model and is not verified by controlled physiological measurement.
This disagreement is live. It has not settled.
At a glance
- Oldest documented origin
- China; folk scraping with stone, bone, and coins, formalized in TCM by the Ming Dynasty (1368 to 1644).
- Name meaning
- "Gua" = to scrape; "sha" = sand, the term for the petechiae raised during treatment.
- Best-supported mechanism
- About a fourfold rise in surface microcirculation lasting roughly 25 minutes (Nielsen 2007 laser Doppler pilot, 11 subjects).
- Evidence ceiling
- Small RCTs and low-quality systematic reviews; no large blinded sham-controlled trials to date.
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Gua Sha. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.